DK357588A - Fremgangsmaade til fremstilling af en farmaceutisk komposition indeholdende 1,3-bis(2-carboxychromon-5-yloxy)-propan-2-ol - Google Patents

Fremgangsmaade til fremstilling af en farmaceutisk komposition indeholdende 1,3-bis(2-carboxychromon-5-yloxy)-propan-2-ol

Info

Publication number
DK357588A
DK357588A DK357588A DK357588A DK357588A DK 357588 A DK357588 A DK 357588A DK 357588 A DK357588 A DK 357588A DK 357588 A DK357588 A DK 357588A DK 357588 A DK357588 A DK 357588A
Authority
DK
Denmark
Prior art keywords
carboxychromon
yloxy
propan
bis
preparing
Prior art date
Application number
DK357588A
Other languages
English (en)
Other versions
DK156876B (da
DK156876C (da
DK357588D0 (da
Inventor
Kenneth Brown
Neil Arthur Stevenson
William Francis Kirk
Clive Booles
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26238506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK357588(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB3672/76A external-priority patent/GB1562901A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of DK357588A publication Critical patent/DK357588A/da
Publication of DK357588D0 publication Critical patent/DK357588D0/da
Publication of DK156876B publication Critical patent/DK156876B/da
Application granted granted Critical
Publication of DK156876C publication Critical patent/DK156876C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
DK357588A 1976-01-30 1988-06-29 Fremgangsmaade til fremstilling af en farmaceutisk komposition indeholdende 1,3-bis(2-carboxychromon-5-yloxy)-propan-2-ol DK156876C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB3672/76A GB1562901A (en) 1976-01-30 1976-01-30 Disodium cromoglycate
GB367276 1976-01-30
GB5113676 1976-12-08
GB5113676 1976-12-08

Publications (4)

Publication Number Publication Date
DK357588A true DK357588A (da) 1988-06-29
DK357588D0 DK357588D0 (da) 1988-06-29
DK156876B DK156876B (da) 1989-10-16
DK156876C DK156876C (da) 1990-03-12

Family

ID=26238506

Family Applications (2)

Application Number Title Priority Date Filing Date
DK038077A DK154766C (da) 1976-01-30 1977-01-28 Fremgangsmaade til fremstilling af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol i specifik form
DK357588A DK156876C (da) 1976-01-30 1988-06-29 Fremgangsmaade til fremstilling af en farmaceutisk komposition indeholdende 1,3-bis(2-carboxychromon-5-yloxy)-propan-2-ol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK038077A DK154766C (da) 1976-01-30 1977-01-28 Fremgangsmaade til fremstilling af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol i specifik form

Country Status (14)

Country Link
JP (1) JPS5294411A (da)
AU (1) AU512593B2 (da)
DE (1) DE2703119A1 (da)
DK (2) DK154766C (da)
ES (1) ES455478A1 (da)
FI (1) FI770215A (da)
FR (1) FR2339604A1 (da)
IE (1) IE44760B1 (da)
IL (1) IL51314A (da)
LU (1) LU76661A1 (da)
NL (1) NL185446C (da)
NO (2) NO151860C (da)
NZ (1) NZ183157A (da)
SE (2) SE442268B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
CY1333A (en) * 1980-04-30 1986-10-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
JPS63138228U (da) * 1987-03-05 1988-09-12
JPS63138229U (da) * 1987-03-05 1988-09-12
EP0338670B1 (en) * 1988-03-22 1994-05-11 FISONS plc Pharmaceutical Compositions
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
GB8829478D0 (en) * 1988-12-16 1989-02-01 Harris Pharma Ltd Formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
AU663906B2 (en) * 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
CA2455115C (en) 1991-12-12 2008-05-27 Glaxo Group Limited Pharmaceutical aerosol formulation
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
NZ246421A (en) 1991-12-18 1996-05-28 Minnesota Mining & Mfg Aerosol formulation containing a drug and a propellant and which is substantially free of surfactant
ES2234266T3 (es) 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
EP1102579B1 (de) * 1998-08-04 2003-03-19 Jago Research Ag Medizinische aerosolformulierungen
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
MX2009008582A (es) 2007-02-11 2009-10-30 Map Pharmaceuticals Inc Metodo para la administracion terapeutica de dihidroergotamina para permitir un rapido alivio de la migraña mientras se minimiza el perfil de efectos secundarios.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (da) * 1956-03-21 1900-01-01
BE556587A (da) * 1957-01-31 1957-04-11
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NL7700911A (nl) 1977-08-02
NO151860C (no) 1985-06-19
DK38077A (da) 1977-07-31
IL51314A0 (en) 1977-03-31
IL51314A (en) 1980-03-31
SE7700888L (sv) 1977-07-31
DK154766B (da) 1988-12-19
IE44760L (en) 1977-07-30
JPS6129929B2 (da) 1986-07-10
NL185446B (nl) 1989-11-16
FR2339604B1 (da) 1980-12-05
SE442268B (sv) 1985-12-16
DK154766C (da) 1989-05-22
LU76661A1 (da) 1977-08-03
NO770286L (no) 1977-08-02
DK156876B (da) 1989-10-16
NZ183157A (en) 1979-08-31
NO151860B (no) 1985-03-11
SE8107278L (sv) 1981-12-04
FI770215A (da) 1977-07-31
SE442267B (sv) 1985-12-16
DE2703119A1 (de) 1977-08-04
DK156876C (da) 1990-03-12
FR2339604A1 (fr) 1977-08-26
AU512593B2 (en) 1980-10-16
JPS5294411A (en) 1977-08-09
DE2703119C2 (da) 1990-10-25
NO780183L (no) 1977-08-02
NL185446C (nl) 1990-04-17
ES455478A1 (es) 1978-02-01
AU2162677A (en) 1978-08-03
IE44760B1 (en) 1982-03-24
DK357588D0 (da) 1988-06-29

Similar Documents

Publication Publication Date Title
DK156876C (da) Fremgangsmaade til fremstilling af en farmaceutisk komposition indeholdende 1,3-bis(2-carboxychromon-5-yloxy)-propan-2-ol
DK298176A (da) Fremgangsmade til fremstilling af 1,4-dihydropyrinderivater
DK153440C (da) Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat
DK563377A (da) R fremgangsmaade til fremstilling af 1,4-dihydropyridinderivate
DK528879A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende isosorbiddinitrat
DK469379A (da) Fremgangsmaade til fremstilling af 1-hydroxylerede 5,6-vitamind-forbindelser
DK476180A (da) Fremgangsmaade til fremstilling af tabletter
DK157060C (da) Fremgangsmaade til fremstilling af en liposomsuspension, der indeholder et laegemiddel
MX150158A (es) Procedimiento para preparar 3,3-bis(aril)ftalidas
DK55677A (da) Fremgangsmade til fremstilling af derivater af 1,2-dithiol
DK180277A (da) Fremgangsmade til fremstilling af polyprenylderivater
DK243477A (da) Fremgangsmade til fremstilling af 10,19-dihydrovitamin d forbindelser
DK117677A (da) Fremgangsmade til fremstilling af piperidinderivater
DK159787C (da) Fremgangsmaade til fremstilling af 3',4'-dideoxykanamycin b
DK329577A (da) Fremgangsmade til fremstilling af derivater af phenoxyhydroxypropylamin
DK185977A (da) Fremgangsmade til fremstilling af 1,3-dihydroheteroarylspiro (isobenzofuraner)
DK38577A (da) Fremgangsmade til fremstilling af betalactamholdige forbindelser
DK301277A (da) Fremgangsmade til fremstilling af substituerede 2,6-methano-2h-1-benzoxociner
DK123578A (da) Fremgangsmaade til fremstilling af 3-(2-aminoethylthio-6-ethyl-7-oxo-1-azabicyclo-(3,2,0)hept-2-en-2-carboxylsyre
DK73077A (da) Fremgangsmade til fremstilling af 2,9-dioxatricyclo (4,3,1,03,7) decaner
DK150299C (da) Analogifremgangsmaade til fremstilling af 8-aminoalkyl-tetracyclo(4,3,0,02,4,03,7)nonanderivater
DK105178A (da) Fremgangsmaade til fremstilling af 2,1,3-thiadiazin-4-on-2,2-dioxid-derivater
DK475376A (da) Fremgangsmade til fremstilling af 2,9-dioxatricyclo/4,3,1,03,7/decan-forbindelser
SE426055B (sv) Forfarande for framstellning av ett keramiskt foremal, som innehaller aluminos keatit
DK330678A (da) Fremgangsmaade til fremstilling af 10,11-dihydro11-oxodibenzo (b,f) thipin-forbindelser